Differentiated thyroid carcinoma (DTC), either papillary or follicular, has usually a very good prognosis with an overall mortality of less than 10%. In recent decades, the clinical presentation of DTC has been changing from advanced cases requiring intense treatment and surveillance to cancer detected by fortuitous neck ultrasonography requiring less aggressive treatment and follow-up. Given the changing presentation of DTC in the last years, the aim of DTC follow-up is to ensure the most effective and less invasive follow-up for a disease that nowadays is mostly cured just with surgery and is rarely fatal. The concept of "Ongoing Risk Stratification" or "Delayed Risk Stratification" which better define the patient risk based on the results of the initial treatment, can maximize the beneficial effects of aggressive therapy in patients with DTC who are likely to benefit from it, while minimizing potential complications and side effects in low-risk patients who will achieve complete remission.

Pacini, F., Castagna, M.G. (2012). New insight in the follow-up strategies of differentiated thyroid cancer. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 35(6 Suppl), 36-9-39.

New insight in the follow-up strategies of differentiated thyroid cancer

PACINI, FURIO;Castagna, M. G.
2012-01-01

Abstract

Differentiated thyroid carcinoma (DTC), either papillary or follicular, has usually a very good prognosis with an overall mortality of less than 10%. In recent decades, the clinical presentation of DTC has been changing from advanced cases requiring intense treatment and surveillance to cancer detected by fortuitous neck ultrasonography requiring less aggressive treatment and follow-up. Given the changing presentation of DTC in the last years, the aim of DTC follow-up is to ensure the most effective and less invasive follow-up for a disease that nowadays is mostly cured just with surgery and is rarely fatal. The concept of "Ongoing Risk Stratification" or "Delayed Risk Stratification" which better define the patient risk based on the results of the initial treatment, can maximize the beneficial effects of aggressive therapy in patients with DTC who are likely to benefit from it, while minimizing potential complications and side effects in low-risk patients who will achieve complete remission.
2012
Pacini, F., Castagna, M.G. (2012). New insight in the follow-up strategies of differentiated thyroid cancer. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 35(6 Suppl), 36-9-39.
File in questo prodotto:
File Dimensione Formato  
Follow-up suppl.pdf

non disponibili

Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 117.37 kB
Formato Adobe PDF
117.37 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/973372